Recce Pharmaceuticals
-
Ticker
RCE
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Sydney, Australia
Recce Pharmaceuticals Ltd is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs. Recce Pharmaceuticals has validated an automated process to manufacture its lead compound ahead of first-in-human clinical trials.
REPORT RATINGS
4.8 / 5.0 (82)
Recce Pharmaceuticals reports have an aggregate usefulness score of 4.8 based on 82 reviews.
Recce Pharmaceuticals
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports